| Page 1508 | Kisaco Research
 

Caroline Wilkinson

Founder
Barket Place

Caroline Wilkinson

Founder
Barket Place

Caroline Wilkinson

Founder
Barket Place
 

Lucy McKinna

Founder
McKinna Plant Labs

Lucy graduated as a vet from the University of Melbourne in 2007 and has worked in companion animal practice in the UK and the Middle East ever since. Passionate about animals, the environment and corporate responsibility, 5 years ago she had the idea to make a vegan dog food with an ingredient list and a nutritional analysis that made her feel like she was doing a great thing for her dog, as well as the planet, launching the flagship product in the range, Noochy Poochy Adult in June last year.

Lucy McKinna

Founder
McKinna Plant Labs

Lucy McKinna

Founder
McKinna Plant Labs

Lucy graduated as a vet from the University of Melbourne in 2007 and has worked in companion animal practice in the UK and the Middle East ever since. Passionate about animals, the environment and corporate responsibility, 5 years ago she had the idea to make a vegan dog food with an ingredient list and a nutritional analysis that made her feel like she was doing a great thing for her dog, as well as the planet, launching the flagship product in the range, Noochy Poochy Adult in June last year.

 

David Whitehouse

Director, Trade Compliance, Danaher Life Sciences Platform
Danaher Corporation (UK)

David Whitehouse

Director, Trade Compliance, Danaher Life Sciences Platform
Danaher Corporation (UK)

David Whitehouse

Director, Trade Compliance, Danaher Life Sciences Platform
Danaher Corporation (UK)
 

Julia Pike

Global Head of IP
Sandoz

Since March 2020, Julia has been the Global Head of IP for Sandoz. In her previous roles with Sandoz, she has had a leading role in the first wave of US biosimilars litigation, including the first litigations on critical aspects of the governing legislation (the Biologics Price Competition and Innovation Act or BPCIA), culminating in the landmark US Supreme Court decision, Sandoz v Amgen.

 

Julia Pike

Global Head of IP
Sandoz

Julia Pike

Global Head of IP
Sandoz

Since March 2020, Julia has been the Global Head of IP for Sandoz. In her previous roles with Sandoz, she has had a leading role in the first wave of US biosimilars litigation, including the first litigations on critical aspects of the governing legislation (the Biologics Price Competition and Innovation Act or BPCIA), culminating in the landmark US Supreme Court decision, Sandoz v Amgen.

 

Since leaving private practice at Corrs Chambers Westgarth, Julia has been in-house counsel for many years including at Mayne Pharma and Hospira Inc before joining Sandoz in 2008. While there, she has taken on roles in European public affairs and led Sandoz’s global IP litigation function as Global Head of IP Litigation. Through those roles, she has maintained a keen interest in IP strategy and litigation worldwide, including cases arising under the Hatch-Waxman and BPCIA legislation in the US, PM(NOC) regulations in Canada and litigation arising from patent linkage systems around the world. 

 

Dr. Sadegh Riazi

Co-Founder and CEO
CipherMode Labs

Dr. Sadegh Riazi is a technology enthusiast, currently co-founder and CEO of CipherMode Labs. He received his Ph.D. in secure computation from UC San Diego where he was awarded the best Ph.D. thesis award. Sadegh founded Project HEAX at Microsoft Research (a new computing platform for Homomorphic Encryption). Prior to that, he studied Electrical Engineering and designed a new system for Brain-Computer Interfaces.

Dr. Sadegh Riazi

Co-Founder and CEO
CipherMode Labs

Dr. Sadegh Riazi

Co-Founder and CEO
CipherMode Labs

Dr. Sadegh Riazi is a technology enthusiast, currently co-founder and CEO of CipherMode Labs. He received his Ph.D. in secure computation from UC San Diego where he was awarded the best Ph.D. thesis award. Sadegh founded Project HEAX at Microsoft Research (a new computing platform for Homomorphic Encryption). Prior to that, he studied Electrical Engineering and designed a new system for Brain-Computer Interfaces. Sadegh is a fellow of the Institute for Global Entrepreneur and has received multiple prestigious awards including Richard Newton Young Fellow Award, Jacobs Graduate Student Award, and Silver Medal in International Student Olympiad.

 

Dr. Sadegh Riazi

Co-Founder and CEO
CipherMode Labs

Dr. Sadegh Riazi is a technology enthusiast, currently co-founder and CEO of CipherMode Labs. He received his Ph.D. in secure computation from UC San Diego where he was awarded the best Ph.D. thesis award. Sadegh founded Project HEAX at Microsoft Research (a new computing platform for Homomorphic Encryption). Prior to that, he studied Electrical Engineering and designed a new system for Brain-Computer Interfaces.

Dr. Sadegh Riazi

Co-Founder and CEO
CipherMode Labs

Dr. Sadegh Riazi

Co-Founder and CEO
CipherMode Labs

Dr. Sadegh Riazi is a technology enthusiast, currently co-founder and CEO of CipherMode Labs. He received his Ph.D. in secure computation from UC San Diego where he was awarded the best Ph.D. thesis award. Sadegh founded Project HEAX at Microsoft Research (a new computing platform for Homomorphic Encryption). Prior to that, he studied Electrical Engineering and designed a new system for Brain-Computer Interfaces. Sadegh is a fellow of the Institute for Global Entrepreneur and has received multiple prestigious awards including Richard Newton Young Fellow Award, Jacobs Graduate Student Award, and Silver Medal in International Student Olympiad.

Sample Attendee List 2022
RNA Therapeutic Modalities Sample Attendee List 2022
Sample Attendee List 2022
 

Jessica McCreadie

Principal
Octopus Ventures

Jess sits in the Health team, and her focus is engaging with, investing in and supporting Europe’s most promising health tech companies.

“The gap between health and life expectancy is widening and to improve quality of life in later years we need a more decentralised, preventative and personalised approach to healthcare.”

Jessica McCreadie

Principal
Octopus Ventures

Jessica McCreadie

Principal
Octopus Ventures

Jess sits in the Health team, and her focus is engaging with, investing in and supporting Europe’s most promising health tech companies.

“The gap between health and life expectancy is widening and to improve quality of life in later years we need a more decentralised, preventative and personalised approach to healthcare.”

Prior to joining Octopus Ventures in June 2021, Jess led the health tech investing team at Legal & General supporting leading health innovations. She invested balance sheet capital into early-stage health tech businesses and supported scale up via board representation in her portfolio.

Earlier in her career Jess invested into and was a banker in a range of alternative asset classes including renewable energy, real estate, and Venture Capital Funds. Jess has a passion for sustainability and delivering social impact alongside economic value.

Outside of work Jess can be found enjoying London’s restaurants, cycling, running, trying out the newest fitness class on offer, or in the park running around with / after her dog.